Vania Leung1, Kristen Wroblewski2, L Philip Schumm2, Megan Huisingh-Scheetz3, Elbert S Huang4. 1. Department of Academic Internal Medicine and Geriatrics, University of Illinois at Chicago, USA. 2. Department of Public Health Sciences, University of Chicago, Illinois, USA. 3. Section of Geriatrics and Palliative Medicine, University of Chicago, Illinois, USA. 4. Section of General Internal Medicine, University of Chicago, Illinois, USA.
Abstract
BACKGROUND: Limited research has been conducted to risk stratify older adults with diabetes. Our objective was to reexamine the 2005-2006 classification systems in participants who are now 5 years older. METHODS: We examined a subsample of 884 community-residing older adults with the diagnosis of diabetes from the National Social Life, Health, and Aging Project. The primary objective was to utilize a latent class analysis (LCA) to fit a model to 11 comorbidities, comparing the 2010-2011 LCA model to that of 2005-2006. The secondary objective was to evaluate the association of the identified classes with frailty, disability, and 5-year mortality. RESULTS: Both 2005-2006 LCA and the 2010-2011 LCA model fit 3 similar comorbidity profiles: Class 1 with the lowest rates of nearly all comorbidities, Class 2 had highest rates of obesity, hypertension, arthritis, and incontinence, and Class 3 had the higher rates of myocardial infarctions, congestive heart failure, and stroke. When compared to the healthier Class 1 (class probability = 0.67), participants with a comorbidity profile with more prevalent cardiovascular conditions (Class 3; 0.09) were at higher risk of frailty and mortality, but not disability; whereas participants with a comorbidity profile with more prevalent geriatric syndrome conditions (Class 2; 0.24) were at higher risk of frailty and disability, but not mortality. CONCLUSIONS: We reconfirmed 3 latent classes with distinct comorbidity profiles among older adults with diabetes. However, the complex relationships between comorbidity classes with frailty, disability, and mortality will likely require revision of the current rationale for stratified goal setting and treatment selection.
BACKGROUND: Limited research has been conducted to risk stratify older adults with diabetes. Our objective was to reexamine the 2005-2006 classification systems in participants who are now 5 years older. METHODS: We examined a subsample of 884 community-residing older adults with the diagnosis of diabetes from the National Social Life, Health, and Aging Project. The primary objective was to utilize a latent class analysis (LCA) to fit a model to 11 comorbidities, comparing the 2010-2011 LCA model to that of 2005-2006. The secondary objective was to evaluate the association of the identified classes with frailty, disability, and 5-year mortality. RESULTS: Both 2005-2006 LCA and the 2010-2011 LCA model fit 3 similar comorbidity profiles: Class 1 with the lowest rates of nearly all comorbidities, Class 2 had highest rates of obesity, hypertension, arthritis, and incontinence, and Class 3 had the higher rates of myocardial infarctions, congestive heart failure, and stroke. When compared to the healthier Class 1 (class probability = 0.67), participants with a comorbidity profile with more prevalent cardiovascular conditions (Class 3; 0.09) were at higher risk of frailty and mortality, but not disability; whereas participants with a comorbidity profile with more prevalent geriatric syndrome conditions (Class 2; 0.24) were at higher risk of frailty and disability, but not mortality. CONCLUSIONS: We reconfirmed 3 latent classes with distinct comorbidity profiles among older adults with diabetes. However, the complex relationships between comorbidity classes with frailty, disability, and mortality will likely require revision of the current rationale for stratified goal setting and treatment selection.
Authors: Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair Journal: J Clin Endocrinol Metab Date: 2019-05-01 Impact factor: 5.958
Authors: Christine T Cigolle; Mohammed U Kabeto; Pearl G Lee; Caroline S Blaum Journal: J Gerontol A Biol Sci Med Sci Date: 2012-04-06 Impact factor: 6.053
Authors: Elbert S Huang; Neda Laiteerapong; Jennifer Y Liu; Priya M John; Howard H Moffet; Andrew J Karter Journal: JAMA Intern Med Date: 2014-02-01 Impact factor: 21.873
Authors: A J Sinclair; A Abdelhafiz; T Dunning; M Izquierdo; L Rodriguez Manas; I Bourdel-Marchasson; J E Morley; M Munshi; J Woo; B Vellas Journal: J Frailty Aging Date: 2018
Authors: Olive Tang; Kunihiro Matsushita; Josef Coresh; A Richey Sharrett; John W McEvoy; B Gwen Windham; Christie M Ballantyne; Elizabeth Selvin Journal: Diabetes Care Date: 2019-11-27 Impact factor: 17.152
Authors: Boris Draznin; Vanita R Aroda; George Bakris; Gretchen Benson; Florence M Brown; RaShaye Freeman; Jennifer Green; Elbert Huang; Diana Isaacs; Scott Kahan; Jose Leon; Sarah K Lyons; Anne L Peters; Priya Prahalad; Jane E B Reusch; Deborah Young-Hyman Journal: Diabetes Care Date: 2022-01-01 Impact factor: 19.112
Authors: Sabrina Ahmed; Mithila Faruque; Mohammad Moniruzzaman; Naym Uddin Roby; Fatema Ashraf; Yuichiro Yano; Katsuyuki Miura; M S A Mansur Ahmed Journal: Endocrinol Diabetes Metab Date: 2022-08-14